Invivyd (IVVD) Non Operating Income (2021 - 2025)

Invivyd (IVVD) posted Non Operating Income of $1.5 million for Q4 2025, up 168.54% on a QoQ basis from $553000.0 in Q3 2025, and up 88.93% year-over-year from $786000.0 in Q4 2024.

Invivyd (IVVD) Non Operating Income (2021 - 2025) Analysis & Trends

Invivyd's Non Operating Income history runs 5 years deep, the most recent figure standing at $1.5 million for Q4 2025.

  • Quarterly Non Operating Income rose 88.93% year-over-year to $1.5 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $3.1 million (down 55.82% YoY) and the FY2025 annual result came in at $3.1 million, down 55.82% from the prior year.
  • Non Operating Income was $1.5 million for Q4 2025 at Invivyd, up from $553000.0 in the prior quarter.
  • Across five years, Non Operating Income topped out at $3.8 million in Q1 2023 and bottomed at $9000.0 in Q1 2021.
  • A 5-year average of $1.5 million and a median of $1.1 million in 2024 frame the typical range for Non Operating Income.
  • Annual changes were most pronounced in 2022 — Non Operating Income soared 7479.17% — and 2025, when it sank 80.0%.
  • Invivyd's Non Operating Income stood at $48000.0 in 2021, then surged by 7479.17% to $3.6 million in 2022, then retreated by 14.84% to $3.1 million in 2023, then sank by 74.63% to $786000.0 in 2024, then jumped by 88.93% to $1.5 million in 2025.
  • Business Quant data shows IVVD's Non Operating Income at $1.5 million in Q4 2025, $553000.0 in Q3 2025, and $400000.0 in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Oculis Holding AG 66,981.90 Bn 66,981.62 Bn - -9.22 Mn
2 Nanobiotix 1,913.50 Bn 1,913.44 Bn - -
3 Akari Therapeutics 959.56 Bn 959.56 Bn - 444,000.00
4 BeOne Medicines 472.03 Bn 467.24 Bn 1.35 Bn -
5 Vertex Pharmaceuticals 122.09 Bn 114.84 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 70.01 Bn 61.26 Bn 3.31 Bn 188.30 Mn
7 Belite Bio 62.34 Bn 62.34 Bn - 5.75 Mn
8 Argenx Se 55.99 Bn 50.80 Bn 1.41 Bn -
9 Alnylam Pharmaceuticals 37.49 Bn 34.48 Bn 959.66 Mn -46.98 Mn
10 Invivyd 105.60 Mn -121.09 Mn 16.07 Mn 1.49 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 1.49 Mn
Sep 30, 2025 553,000.00
Jun 30, 2025 400,000.00
Mar 31, 2025 633,000.00
Dec 31, 2024 786,000.00
Sep 30, 2024 1.57 Mn
Jun 30, 2024 2.00 Mn
Mar 31, 2024 2.59 Mn
Dec 31, 2023 3.10 Mn
Sep 30, 2023 3.62 Mn
Jun 30, 2023 3.65 Mn
Mar 31, 2023 3.75 Mn
Dec 31, 2022 3.64 Mn
Sep 30, 2022 2.24 Mn
Jun 30, 2022 759,000.00
Mar 31, 2022 73,000.00
Dec 31, 2021 48,000.00
Sep 30, 2021 43,000.00
Jun 30, 2021 18,000.00
Mar 31, 2021 9,000.00